Quantitative 68Ga-PSMA-11 PET and Outcomes in Metastatic Castration-resistant Prostate Cancer following 177Lu-PSMA-617

Update: 2024-10-22

Description

Dr. Ashwin Singh Parihar speaks with Dr. Phillip Kuo, Dr. Andrew Armstrong, and Dr. Ken Herrmann about how ⁶⁸Ga-PSMA-11 PET can predict response of metastatic prostate cancer following ¹⁷⁷Lu-PSMA-617 therapy. The VISION Trial.

Quantitative ⁶⁸Ga-PSMA-11 PET and ClinicalOutcomes in Metastatic Castration-resistant ProstateCancer Following ¹⁷⁷Lu-PSMA-617 (VISION Trial). Kuo and Morris et al. Radiology 2024; 312(2):e233460.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

AI in Radiology: Transforming Workflows & Efficiency – Sponsored by Carestream Health

2024-11-1924:45

Smart Imaging: AI in MRI Technology-Sponsored by AIRS Medical

2024-11-1213:56

AI and the Future of Breast Diagnosis- Sponsored by Carestream Health

2024-11-0522:19

Nov 2024 United States Election Day: Understanding Election Result Projections

2024-10-3125:42

Seeing Beyond: How Imaging Transforms Patient Portals-Sponsored by Hyland Healthcare

2024-10-2920:36

Quantitative 68Ga-PSMA-11 PET and Outcomes in Metastatic Castration-resistant Prostate Cancer following 177Lu-PSMA-617

2024-10-2230:54

Treatment of Medium Vessel Occlusion Acute Ischemic Stroke

2024-10-1536:28

Lexicon for First-Trimester US

2024-10-0824:41

Opportunistic Screening of Osteoporosis

2024-10-0115:33

Optic Nerve US to Predict Intracranial Pressure - sponsored by Mayo Clinic

2024-09-2408:52

Normalized Join-Count for Predicting Emphysema Progression

2024-09-1719:26

Neuroimaging in the Era of Anti-Amyloid Therapies-Sponsored by GE HealthCare

2024-09-1050:15

Driving patient care access in Emerging Markets: Global Learning Center and experience at Muhimbili Hospital, Tanzania – Sponsored by GE HealthCare

2024-09-0339:01

Impact of Patient Characteristics on Digital Breast Tomosynthesis AI Performance

2024-08-2720:35

Impact of Positive Leadership on Burnout and Engagement

2024-08-2016:52

Y-90 Radiation Segmentectomy for HCC

2024-08-1317:43

NASH, Liver MR Elastography, and LI-RADS CEUS

2024-08-0621:28

18F-PSMA-1007 PET/CT - sponsored by Mayo Clinic

2024-07-3018:06

Endovascular Revascularization in Patients with Acute Arterial Mesenteric Ischemia

2024-07-2317:21

Theranostics for Prostate Cancer

2024-07-1628:46

00:00

1.0x

Quantitative 68Ga-PSMA-11 PET and Outcomes in Metastatic Castration-resistant Prostate Cancer following 177Lu-PSMA-617

#box-pro-ellipsis-173243148160683{-webkit-line-clamp:2;}Quantitative 68Ga-PSMA-11 PET and Outcomes in Metastatic Castration-resistant Prostate Cancer following 177Lu-PSMA-617

Quantitative 68Ga-PSMA-11 PET and Outcomes in Metastatic Castration-resistant Prostate Cancer following 177Lu-PSMA-617

Quantitative 68Ga-PSMA-11 PET and Outcomes in Metastatic Castration-resistant Prostate Cancer following 177Lu-PSMA-617